Literature DB >> 7336367

Benign asbestos pleural effusion: diagnosis and course.

B W Robinson, A W Musk.   

Abstract

We have reviewed 22 patients with benign asbestos pleural effusion seen over a 17-year period. The mean duration of exposure to asbestos was 5.5 years and the mean interval between exposure and presentation was 16.3 years. In five the effusion was asymptomatic. Fever was uncommon but in 15 of 21 patients the ESR was elevated. Leucocytosis was noted in seven of 20 patients. Autoantibodies were rarely detected. The pleural fluid was usually blood-stained and the volume aspirated was rarely larger than 500 ml. Pleural biopsies revealed established pleural fibrosis and/or inflammatory infiltration with fibrinous exudate and mesothelial and fibroblastic proliferation. A positive mantoux test was noted in eight of 12 patients but there was no other evidence of tuberculosis. The mean duration to spontaneous resolution of the effusion was 4.3 months. During a follow-up period of 28.1 years from initial exposure to asbestos (mean 22.8 years) and up to 17.2 years from initial presentation with a pleural effusion (mean 6.3 years) seven patients had a single recurrence and only one patient had multiple pleural effusions. Only three patients experienced persistent pleural pain. It was not possible to predict the likelihood of recurrence of an effusion or the persistence of pleural pain from the data at presentation. No patient subsequently developed mesothelioma or other neoplasm.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7336367      PMCID: PMC471853          DOI: 10.1136/thx.36.12.896

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  12 in total

1.  [Benign asbestos-induced pleurisy (author's transl)].

Authors:  G Nyiredy
Journal:  Prax Pneumol       Date:  1975-03

2.  [Letter: Nontumoral asbestos pleurisy. Apropos of 4 cases].

Authors:  J Leménager; P Rousselot; L Le Bouffant
Journal:  Nouv Presse Med       Date:  1975-04-12

Review 3.  Asbestos and mesothelioma: a review.

Authors:  M Kannerstein; J Churg; W T McCaughey
Journal:  Pathol Annu       Date:  1978

Review 4.  Asbestos-related diseases of the lung and other organs: their epidemiology and implications for clinical practice.

Authors:  M R Becklake
Journal:  Am Rev Respir Dis       Date:  1976-07

5.  Letter: Pleural effusion in asbestosis.

Authors:  H B Eisenstadt
Journal:  N Engl J Med       Date:  1974-05-02       Impact factor: 91.245

6.  Acute pleurisy in asbestos exposed persons.

Authors:  G K Sluis-Cremer; I Webster
Journal:  Environ Res       Date:  1972-12       Impact factor: 6.498

7.  The early radiological changes in pulmonary and pleural asbestosis.

Authors:  D E Fletcher; J R Edge
Journal:  Clin Radiol       Date:  1970-10       Impact factor: 2.350

8.  Asbestos pleural effusion.

Authors:  E A Gaensler; A I Kaplan
Journal:  Ann Intern Med       Date:  1971-02       Impact factor: 25.391

9.  Respiratory function changes after asbestos pleurisy.

Authors:  P H Wright; A Hanson; L Kreel; L H Capel
Journal:  Thorax       Date:  1980-01       Impact factor: 9.139

10.  Unsuspected exposure to asbestos and bronchogenic carcinoma.

Authors:  K M Martischnig; D J Newell; W C Barnsley; W K Cowan; E L Feinmann; E Oliver
Journal:  Br Med J       Date:  1977-03-19
View more
  12 in total

1.  BTS guidelines for the investigation of a unilateral pleural effusion in adults.

Authors:  N A Maskell; R J A Butland
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  Pleural effusion in silicosis of the lung.

Authors:  F A al-Kassimi
Journal:  Br J Ind Med       Date:  1992-06

3.  Evidence of a role for mesothelial cell-derived interleukin 8 in the pathogenesis of asbestos-induced pleurisy in rabbits.

Authors:  A M Boylan; C Rüegg; K J Kim; C A Hébert; J M Hoeffel; R Pytela; D Sheppard; I M Goldstein; V C Broaddus
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

4.  Pleurectomy for persistent pain in benign asbestos-related pleural disease.

Authors:  D I Fielding; J L McKeon; W A Oliver; K Matar; I G Brown
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

5.  Asbestos pleural effusion: a clinical entity.

Authors:  G Mårtensson; S Hagberg; K Pettersson; G Thiringer
Journal:  Thorax       Date:  1987-09       Impact factor: 9.139

6.  Chronic pleuritic pain in four patients with asbestos induced pleural fibrosis.

Authors:  A Miller
Journal:  Br J Ind Med       Date:  1990-03

7.  Clinical Investigation of Benign Asbestos Pleural Effusion.

Authors:  Nobukazu Fujimoto; Kenichi Gemba; Keisuke Aoe; Katsuya Kato; Takako Yokoyama; Ikuji Usami; Kazuo Onishi; Keiichi Mizuhashi; Toshikazu Yusa; Takumi Kishimoto
Journal:  Pulm Med       Date:  2015-11-24

8.  MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion.

Authors:  Guntulu Ak; Sandra C Tomaszek; Farhad Kosari; Muzaffer Metintas; James R Jett; Selma Metintas; Huseyin Yildirim; Emine Dundar; Jie Dong; Marie Christine Aubry; Dennis A Wigle; Charles F Thomas
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

Review 9.  Pleural effusion: diagnosis, treatment, and management.

Authors:  Vinaya S Karkhanis; Jyotsna M Joshi
Journal:  Open Access Emerg Med       Date:  2012-06-22

10.  Malignant pleural mesothelioma presenting with remitting-relapsing pleural effusions: report of two cases.

Authors:  Sanjeevan Muruganandan; Deirdre Brigid Fitzgerald; Y C Gary Lee
Journal:  Respirol Case Rep       Date:  2018-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.